[Articles] Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study

Dulaglutide in combination with lispro resulted in a significantly greater improvement in glycaemic control than did glargine and represents a new treatment option for patients unable to achieve glycaemic targets with conventional insulin treatment.

Source: LANCET - May 22, 2015 Category: Journals (General) Authors: Lawrence Blonde, Johan Jendle, Jorge Gross, Vincent Woo, Honghua Jiang, Jessie L Fahrbach, Zvonko Milicevic Tags: Articles Source Type: research